LA VÉRITÉ À PROPOS DE LA GÉNÉTIQUE DE LA PSYCHOSE: UNE HISTOIRE SANS FIN OU UNE HISTOIRE QUI TOUCHE BIENTÔT À SA FIN? = THE TRUTH ABOUT GENETICS OF PSYCHOSIS : AN ENDLESS STORY OR A SOON-ENDING STORY ?VAN WINKEL, Ruud.Acta psychiatrica belgica. 2010, pp 17-18, issn 0300-8967, 2 p., SUP1Article

Intermediate Phenotype Analysis of Patients, Unaffected Siblings, and Healthy Controls Identifies VMAT2 as a Candidate Gene for Psychotic Disorder and NeurocognitionSIMONS, Claudia J. P; VAN WINKEL, Ruud.Schizophrenia bulletin. 2013, Vol 39, Num 4, pp 848-856, issn 0586-7614, 9 p.Article

Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent? A Literature Review : Early career psychiatristsSIMON, Viktoria; VAN WINKEL, Ruud; DE HERT, Marc et al.The Journal of clinical psychiatry. 2009, Vol 70, Num 7, pp 1041-1050, issn 0160-6689, 10 p.Article

Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of Cannabis: Sibling Analysis and Proband Follow-upVAN WINKEL, Ruud.Archives of general psychiatry. 2011, Vol 68, Num 2, pp 148-157, issn 0003-990X, 10 p.Article

AKT I Moderation of Cannabis-Induced Cognitive Alterations in Psychotic DisorderVAN WINKEL, Ruud; VAN BEVEREN, Nico J. M; SIMONS, Claudia et al.Neuropsychopharmacology (New York, NY). 2011, Vol 36, Num 12, pp 2529-2537, issn 0893-133X, 9 p.Article

Psychosocial Stress and Psychosis. A Review of the Neurobiological Mechanisms and the Evidence for Gene-Stress Interaction : Schizophrenia aetiology: from G to GxEVAN WINKEL, Ruud; STEFANIS, Nicholas C; MYIN-GERMEYS, Inez et al.Schizophrenia bulletin. 2008, Vol 34, Num 6, pp 1095-1105, issn 0586-7614, 11 p.Article

Anticholinergic use in hospitalised schizophrenic patients in BelgiumDE HERT, Marc; WAMPERS, Martien; VAN WINKEL, Ruud et al.Psychiatry research. 2007, Vol 152, Num 2-3, pp 165-172, issn 0165-1781, 8 p.Article

Childhood Trauma as a Cause of Psychosis: Linking Genes, Psychology, and BiologyVAN WINKEL, Ruud; VAN NIEROP, Martine; MYIN-GERMEYS, Inez et al.Canadian journal of psychiatry. 2013, Vol 58, Num 1, pp 44-51, issn 0706-7437, 8 p.Article

Evidence that the impact of hearing impairment on psychosis risk is moderated by the level of complexity of the social environmentVAN DER WERF, Margriet; VAN WINKEL, Ruud; VAN BOXTEL, Martin et al.Schizophrenia research. 2010, Vol 122, Num 1-3, pp 193-198, issn 0920-9964, 6 p.Article

The relation between neurocognitive dysfunction and impaired insight in patients with schizophreniaSIMON, Viktoria; DE HERT, Marc; WAMPERS, Martien et al.European psychiatry. 2009, Vol 24, Num 4, pp 239-243, issn 0924-9338, 5 p.Article

Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder: A Systematic Review and Exploratory Meta-AnalysisDE HERT, Marc; WEIPING YU; DETRAUX, Johan et al.CNS drugs. 2012, Vol 26, Num 9, pp 733-759, issn 1172-7047, 27 p.Article

Remission criteria for schizophrenia : Evaluation in a large naturalistic cohortDE HERT, Marc; VAN WINKEL, Ruud; WAMPERS, Martien et al.Schizophrenia research. 2007, Vol 92, Num 1-3, pp 68-73, issn 0920-9964, 6 p.Article

Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders: A Systematic Review and Meta-AnalysisMITCHELL, Alex J; VANCAMPFORT, Davy; SWEERS, Kim et al.Schizophrenia bulletin. 2013, Vol 39, Num 2, pp 306-318, issn 0586-7614, 13 p.Article

Common variants at VRK2 and TCF4 conferring risk of schizophreniaSTEINBERG, Stacy; DE JONG, Simone; DEMONTIS, Ditte et al.Human molecular genetics (Print). 2011, Vol 20, Num 20, pp 4076-4081, issn 0964-6906, 6 p.Article

Major Changes in Glucose Metabolism, Including New-Onset Diabetes, Within 3 Months After Initiation of or Switch to Atypical Antipsychotic Medication in Patients With Schizophrenia and Schizoaffective DisorderVAN WINKEL, Ruud; DE HERT, Marc; WAMPERS, Martien et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 3, pp 472-479, issn 0160-6689, 8 p.Article

Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia : A 10-year follow-up studyVAN WINKEL, Ruud; MYIN-GERMEYS, Inez; DELESPAUL, Philippe et al.Schizophrenia research. 2006, Vol 88, Num 1-3, pp 47-54, issn 0920-9964, 8 p.Article

A case series : Evaluation of the metabolic safety of aripiprazoleDE HERT, Marc; HANSSENS, Linda; VAN WINKEL, Ruud et al.Schizophrenia bulletin. 2007, Vol 33, Num 3, pp 823-830, issn 0586-7614, 8 p.Article

MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational studyVAN WINKEL, Ruud; MOONS, Tim; PEERBOOMS, Odette et al.International clinical psychopharmacology. 2010, Vol 25, Num 5, pp 270-276, issn 0268-1315, 7 p.Article

Pharmacological treatment of severe dyslipidaemia in patients with schizophreniaHANSSENS, Linda; DE HERT, Marc; KALNICKA, Dita et al.International clinical psychopharmacology. 2007, Vol 22, Num 1, pp 43-49, issn 0268-1315, 7 p.Article

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medicationDE HERT, Marc A; VAN WINKEL, Ruud; VAN EYCK, Dominique et al.Schizophrenia research. 2006, Vol 83, Num 1, pp 87-93, issn 0920-9964, 7 p.Article

Age at Onset of Psychotic Disorder: Cannabis, BDNF Val66Met, and Sex-Specific Models of Gene—Environment InteractionDECOSTER, Jeroen; JIM VAN OS; KENIS, Gunter et al.American journal of medical genetics. Part B, Neuropsychiatric genetics. 2011, Vol 156, Num 3, pp 363-369, issn 1552-4841, 7 p.Article

Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorderDE HERT, Marc; KALNICKA, Dita; VAN WINKEL, Ruud et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 12, pp 1889-1896, issn 0160-6689, 8 p.Article

No Association Between MTHFR C677T or A1298C and Age at Onset of SchizophreniaPEERBOOMS, Odette; RUTTEN, Bart P. F; DECOSTER, Jeroen et al.American journal of medical genetics. Part B, Neuropsychiatric genetics. 2010, Vol 153, Num 7, pp 1362-1363, issn 1552-4841, 2 p.Article

Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophreniaVANCAMPFORT, Davy; KNAPEN, Jan; PROBST, Michel et al.Psychiatry research (Print). 2010, Vol 177, Num 3, pp 271-279, issn 0165-1781, 9 p.Article

Psychiatric Diagnosis as an Independent Risk Factor for Metabolic Disturbances : Results From a Comprehensive, Naturalistic Screening ProgramVAN WINKEL, Ruud; VAN OS, Jim; CELIC, Ivan et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 8, issn 0160-6689, 1319-1327 [9 p.]Article